177 related articles for article (PubMed ID: 16119196)
1. A quantitative structure-activity relationship study on some aromatic/heterocyclic sulfonamides and their charged derivatives acting as carbonic anhydrase inhibitors.
Gupta SP; Kumaran S
J Enzyme Inhib Med Chem; 2005 Jun; 20(3):251-9. PubMed ID: 16119196
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
[TBL] [Abstract][Full Text] [Related]
3. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
Agrawal VK; Bano S; Supuran CT; Khadikar PV
Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
[TBL] [Abstract][Full Text] [Related]
4. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
Deeb O; Goodarzi M; Khadikar PV
Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
[TBL] [Abstract][Full Text] [Related]
5. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
Wang ZC; Qin YJ; Wang PF; Yang YA; Wen Q; Zhang X; Qiu HY; Duan YT; Wang YT; Sang YL; Zhu HL
Eur J Med Chem; 2013 Aug; 66():1-11. PubMed ID: 23777898
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of red blood cell ostrich (Struthio camelus) carbonic anhydrase with a series of aromatic and heterocyclic sulfonamides.
Ozensoy O; Isik S; Arslan O; Arslan M; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2005 Aug; 20(4):383-7. PubMed ID: 16206834
[TBL] [Abstract][Full Text] [Related]
8. Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.
Krasavin M; Korsakov M; Dorogov M; Tuccinardi T; Dedeoglu N; Supuran CT
Eur J Med Chem; 2015 Aug; 101():334-47. PubMed ID: 26160114
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
[TBL] [Abstract][Full Text] [Related]
10. Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: as antiglaucoma agents.
Kumar S; Singh V; Tiwari M
Med Chem; 2007 Jul; 3(4):379-86. PubMed ID: 17627576
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.
Ilies MA; Vullo D; Pastorek J; Scozzafava A; Ilies M; Caproiu MT; Pastorekova S; Supuran CT
J Med Chem; 2003 May; 46(11):2187-96. PubMed ID: 12747790
[TBL] [Abstract][Full Text] [Related]
12. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
[TBL] [Abstract][Full Text] [Related]
13. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I.
Scozzafava A; Supuran CT
J Enzyme Inhib; 1999; 14(5):343-63. PubMed ID: 10488246
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
